📋 GMP/cGMP Validation Documentation Package
DPP-260 GMP/cGMP Validation Documentation
Complete pharmaceutical validation package — URS, DQ, IQ, OQ, PQ, FAT, SAT protocols, 21 CFR Part 11 audit trail, EN 10204 3.1 material certificates. Free with every DPP-260. FDA, EMA, WHO, CDSCO submission ready.
WHO GMP TRS 961
cGMP 21 CFR 210/211
21 CFR Part 11
EU GMP Annex 15
Pharmaceutical Validation Process: URS → DQ → FAT → IQ → OQ → PQ → SAT
Complete 7-stage pharmaceutical equipment qualification lifecycle for DPP-260, aligned with WHO GMP TRS 961, FDA cGMP, and EU GMP Annex 15 requirements.
1
URS
User Requirements Specification
Define functional, performance, regulatory & operational requirements before design. HIJ provides URS template.
2
DQ
Design Qualification
Verify equipment design meets URS requirements. Engineering drawings, P&ID, material specs reviewed and approved.
3
FAT
Factory Acceptance Test
Pre-shipment testing at HIJ Wenzhou. Performance, alarms, safety, documentation verified before shipping.
4
IQ
Installation Qualification
Verify proper installation: utilities, calibration, documentation. HIJ engineer on-site support.
5
OQ
Operational Qualification
Test machine across operating ranges: speed, temperature, pressure, alarms, electronic records.
6
PQ
Performance Qualification
Verify performance with real product. Three consecutive successful batches at production speed.
7
SAT
Site Acceptance Test
Final acceptance after all qualifications. Documented review and production release sign-off.
Total validation timeline: 18-26 weeks from URS finalization to production release.
15+ Validation Documents Included Free with DPP-260
Complete regulatory-submission-ready documentation package. All documents in English, accepted by FDA, EMA, WHO, and major regulatory authorities globally.
User Requirements Specification
URS Template
Comprehensive URS template aligned with WHO GMP and FDA cGMP requirements.
- Functional requirements (forming, sealing, cutting)
- Performance requirements (speed, accuracy)
- Regulatory requirements (cGMP, 21 CFR Part 11)
- Customizable to client product needs
Design Qualification
DQ Protocol
Documented verification that DPP-260 design meets URS requirements.
- Engineering drawings (mechanical, electrical)
- P&ID diagrams
- Material specifications
- Component supplier certifications
Factory Acceptance Test
FAT Protocol & Report
Pre-shipment performance verification at HIJ Wenzhou facility.
- Visual inspection checklist
- Mechanical & electrical functional tests
- Performance tests (speed, accuracy)
- Alarm and safety tests
Installation Qualification
IQ Protocol
On-site installation verification protocol with HIJ engineer support.
- Utility connection verification
- Calibration verification
- Environmental condition checks
- Documentation completeness review
Operational Qualification
OQ Protocol
Testing machine operation across full operating ranges per specifications.
- Speed range verification (100-6,000 BPH)
- Temperature range tests (forming/sealing)
- Pressure verification (forming pressure)
- Electronic records system tests
Performance Qualification
PQ Protocol
Performance verification under actual production conditions with real product.
- 3 consecutive successful batch runs
- Production-speed validation
- Real product compatibility tests
- Statistical analysis support
21 CFR Part 11 Compliance
Compliance Documentation
Complete electronic records and electronic signatures compliance package.
- Audit trail specification
- Electronic signature procedures
- Access control documentation
- Data integrity protocols
Material Certificates
EN 10204 3.1
Mill-traceable material certificates for all product-contact components.
- AISI 316L stainless steel certificates
- Elastomer FDA 21 CFR 177 compliance
- PTFE seal material certificates
- Food-grade lubricant declarations
Calibration & Maintenance
Records & SOPs
Complete calibration certificates and maintenance procedures.
- Initial calibration certificates (factory)
- Calibration schedule recommendations
- Preventive maintenance procedures
- Spare parts list & change control
Electrical Schematics
Engineering Drawings
Complete electrical and pneumatic schematic drawings.
- Power distribution diagram
- Control circuit schematics
- Pneumatic system drawings
- Signal/communication diagrams
Operator & Maintenance Manuals
Operating SOPs
Complete operating procedures and maintenance manuals in English.
- Standard operating procedures (SOPs)
- Format changeover procedures
- Cleaning procedures (CIP-compatible)
- Troubleshooting guides
Site Acceptance Test
SAT Protocol
Final acceptance test protocol after all qualifications complete.
- Qualification activities review
- Document completeness verification
- Training records review
- Production release sign-off
21 CFR Part 11 Compliance: Electronic Records & Signatures
DPP-260 is fully compliant with US FDA 21 CFR Part 11 for electronic records and electronic signatures — required for FDA-regulated pharmaceutical production and US export markets.
Complete Audit Trail
Automatic logging of all user actions: login/logout, parameter changes, batch start/stop, alarm events, with timestamp accuracy to seconds.
Role-Based Access Control
Multi-level password authentication: Operator, Supervisor, QA, Maintenance, Administrator. Each role has defined permissions per FDA guidance.
Electronic Signatures
FDA-compliant electronic signatures for batch record approval. Each signature includes user ID, timestamp, signing meaning, and reason.
Tamper-Evident Storage
Encrypted audit log storage with version control. Records cannot be deleted or modified by operators or maintenance staff. Read-only audit mode.
Automatic Data Backup
Scheduled automatic backup of all electronic records to secondary storage. Backup integrity verification with checksums per data integrity guidance.
Auditor Export Functions
One-click export of audit trail reports in CSV/PDF for FDA inspector review. Filtered by date range, user, batch, or event type.
NTP Time Synchronization
Network Time Protocol synchronization ensures audit trail timestamp accuracy. Time tampering detection with security alerts.
Validation Documentation
Complete 21 CFR Part 11 compliance documentation provided: system risk assessment, validation matrix, periodic review procedures.
DPP-260 Documentation Accepted by Major Regulators Globally
HIJ DPP-260 validation documentation has successfully passed audits at client pharmaceutical facilities across major regulatory authorities worldwide.
US FDA
21 CFR Parts 210, 211, Part 11
cGMP Compliance
EU EMA
EU GMP EudraLex Volume 4
Annex 15 Qualification
WHO
WHO GMP TRS 961 Annex 6
WHO Prequalification
PIC/S GMP
Pharmaceutical Inspection
Co-operation Scheme
India CDSCO
Schedule M Compliance
State FDA Acceptance
Indonesia BPOM
CPOB Compliance
BPOM Acceptance
Brazil ANVISA
RDC 17/2010 Compliance
ANVISA Acceptance
UK MHRA
UK GMP Compliance
MHRA Acceptance
DPP-260 Validation Package vs Other Suppliers
How HIJ DPP-260 validation documentation compares to other Chinese suppliers and European premium brands.
| Validation Item | HIJ DPP-260 | Other Chinese | European Premium |
|---|---|---|---|
| URS Template | Free | Often missing | Often paid extra |
| Design Qualification (DQ) | Free | Limited or paid | Paid extra |
| Installation Qualification (IQ) | Free | Basic only | Paid extra |
| Operational Qualification (OQ) | Free | Basic only | Paid extra |
| Performance Qualification (PQ) | Free | Often missing | Paid extra |
| FAT (Factory Acceptance Test) | Yes | Limited | Yes |
| SAT (Site Acceptance Test) | Yes | Limited | Yes |
| 21 CFR Part 11 Compliance | Full | Often partial | Full |
| EN 10204 3.1 Material Certs | Yes | Limited | Yes |
| Calibration Certificates | Yes | Basic only | Yes |
| Audit Trail Documentation | Complete | Often missing | Complete |
| FDA Audit-Ready | Yes | Rarely | Yes |
| EMA Audit-Ready | Yes | Rarely | Yes |
| Validation Package Cost | FREE (included) | USD 5,000-10,000 extra | USD 15,000-25,000 extra |
| On-Site IQ/OQ Support | Included | Often paid extra | Paid extra ($1,500-3,000/day) |
DPP-260 Audit Success Record
HIJ machines and validation documentation have successfully passed regulatory audits at client pharmaceutical facilities globally.
FDA Audit Success
Multiple FDA Inspections PassedHIJ DPP-260 machines and validation documentation have successfully passed FDA inspections at client pharmaceutical facilities exporting to United States markets.
- cGMP 21 CFR Parts 210/211 compliance verified
- 21 CFR Part 11 electronic records audit passed
- Documentation completeness confirmed
- No 483 observations on equipment
WHO Prequalification Audit
WHO PQ CompliantDPP-260 machines installed at WHO-PQ-certified pharmaceutical manufacturers producing essential medicines for global health programs.
- WHO GMP TRS 961 Annex 6 compliance
- WHO PQ inspector acceptance
- Validation documentation reviewed and approved
- Critical for pharma export to UNICEF, GAVI markets
EMA / EU GMP Audit
EU Audit PassedHIJ DPP-260 documentation accepted by European Medicines Agency (EMA) inspectors at client facilities exporting to EU markets.
- EU GMP EudraLex Volume 4 compliance
- Annex 15 Qualification & Validation accepted
- Annex 11 Computerized Systems compliance
- EDQM Certificate of Suitability supported
Multi-Country Regulatory Acceptance
15+ Countries AuditedDPP-260 validation documentation accepted across major pharmaceutical regulatory authorities worldwide.
- India CDSCO and state FDA inspections
- Brazil ANVISA RDC 17/2010 compliance
- Indonesia BPOM CPOB acceptance
- UK MHRA, Australia TGA accepted
Frequently Asked Questions
Common questions from QA managers, validation engineers, and regulatory affairs directors about DPP-260 GMP/cGMP validation documentation.
What validation documentation comes with DPP-260?
DPP-260 includes complete pharmaceutical validation documentation package free with every machine: User Requirements Specification (URS) template, Design Qualification (DQ), Installation Qualification (IQ), Operational Qualification (OQ), Performance Qualification (PQ), Factory Acceptance Test (FAT) protocol, Site Acceptance Test (SAT) protocol, calibration records, material certificates (EN 10204 3.1), electrical schematics, P&ID diagrams, operator manuals, and maintenance procedures. All documents in English, regulatory-submission ready for FDA, EMA, WHO, and CDSCO audits.
Is DPP-260 21 CFR Part 11 compliant?
Yes. DPP-260 is fully compliant with 21 CFR Part 11 (Electronic Records and Electronic Signatures). The Siemens PLC system includes: complete audit trail logging all user actions with timestamp and user ID, electronic signature support for batch records, role-based access control with multi-level password authentication, time-stamped electronic records, automatic backup of records, and tamper-evident data storage. Compliant for FDA-regulated pharmaceutical production.
What is the difference between DQ, IQ, OQ, and PQ?
DQ (Design Qualification): documented verification that equipment design meets user requirements. IQ (Installation Qualification): documented verification that equipment is installed correctly per manufacturer specifications and meets all utility requirements. OQ (Operational Qualification): documented verification that equipment operates as intended across operating ranges. PQ (Performance Qualification): documented verification that equipment consistently performs as required under actual production conditions with real product. The complete sequence DQ → IQ → OQ → PQ is required for pharmaceutical equipment qualification per WHO GMP and FDA cGMP.
Does HIJ provide URS templates for DPP-260?
Yes. HIJ provides comprehensive User Requirements Specification (URS) templates aligned with WHO GMP TRS 961, FDA cGMP 21 CFR 211, and EU GMP Annex 15. Templates cover: functional requirements (forming, sealing, cutting, output), performance requirements (speed, accuracy, reliability), regulatory requirements (cGMP, 21 CFR Part 11, EU GMP), operational requirements (cleaning, maintenance, training), and safety requirements (CE, machine safety). Customizable to client-specific product and regulatory needs.
Does HIJ provide on-site validation support?
Yes. HIJ engineers travel on-site for Installation Qualification (IQ) and Operational Qualification (OQ) commissioning at client pharmaceutical facilities globally. Standard service: 5-7 days on-site including: equipment installation verification, utility connection check, calibration verification, OQ test execution, electronic record system setup, operator training (2-3 days), and final IQ/OQ documentation sign-off. Performance Qualification (PQ) is typically executed by client validation team with HIJ remote support.
What about FAT (Factory Acceptance Testing) for DPP-260?
FAT (Factory Acceptance Testing) is conducted at HIJ Wenzhou facility before shipment. Client representative travels to HIJ for in-person FAT, or video FAT is provided remotely. FAT scope includes: visual inspection, mechanical/electrical functional tests, performance tests (speed, accuracy), alarm and safety tests, electronic record system verification, calibration verification, documentation review, and acceptance sign-off. FAT must pass before machine ships. HIJ provides full FAT report with photographs and test data.
Does DPP-260 documentation pass FDA audits?
Yes. HIJ DPP-260 validation documentation has successfully passed FDA inspections at client pharmaceutical facilities exporting to United States markets. Documentation meets FDA requirements per 21 CFR Parts 210, 211, and Part 11 (Electronic Records). DPP-260 has also passed EMA (European Medicines Agency) audits, WHO Prequalification (PQ) audits, and CDSCO (India) inspections. Validation package is regulatory-submission ready in English.
What materials and components have traceability documentation?
All product-contact components have full material traceability via EN 10204 3.1 mill certificates: AISI 316L stainless steel (forming station, sealing station, cutting station, frame contact areas), EPDM/Viton elastomers (FDA 21 CFR 177 compliant), PTFE seals, food-grade lubricants. Critical components also include: Siemens PLC certificate, Schneider/ABB drives certificates, SMC/Festo pneumatic certificates, and Cognex/Keyence vision system certifications (if optional vision installed). Complete bill of materials with traceability provided.
Is DPP-260 audit trail tamper-evident?
Yes. DPP-260 audit trail is fully tamper-evident per 21 CFR Part 11 requirements. Features: automatic logging of all user actions (login, logout, parameter changes, batch start/stop), timestamp accurate to seconds, user ID tracking, password-protected modifications, encrypted audit log storage, automatic backup with version control, exportable audit reports (CSV/PDF), and read-only review mode for auditors. Audit trail records cannot be deleted or modified by operators or maintenance staff.
How long does the complete DPP-260 validation process take?
Typical complete validation timeline: URS finalization (2-3 weeks during pre-order), DQ review (1 week), Manufacturing + FAT (12-16 weeks), Shipping (2-4 weeks), IQ on-site (2-3 days), OQ on-site (3-5 days), PQ by client (2-3 weeks for 3 consecutive batches), final review and sign-off (1 week). Total: 18-26 weeks from URS to production-ready machine. HIJ can accelerate timeline for urgent projects.
Can I review HIJ validation documents before ordering?
Yes. HIJ provides sample validation documentation packages (anonymized) for client review before ordering. Send a request to [email protected] with your company information and intended product application. HIJ engineers will share representative URS template, FAT protocol, IQ/OQ sample, and 21 CFR Part 11 compliance documentation under NDA for your validation team's review.
What if I need customized validation documents for specific regulatory authority?
HIJ engineers customize validation documentation to meet specific regulatory authority requirements. We have prepared customized packages for: FDA (US), EMA (EU), MHRA (UK), TGA (Australia), Health Canada, ANVISA (Brazil), CDSCO (India), BPOM (Indonesia), Thai FDA, PMDA (Japan), and Chinese NMPA. Customization typically adds 1-2 weeks to URS finalization phase. No additional cost for standard regulatory frameworks.
Need DPP-260 Validation Documentation Sample?
Get a sample validation documentation package (anonymized) for your QA/validation team's review. HIJ engineers will respond within 24 hours with URS template, FAT protocol sample, 21 CFR Part 11 compliance docs, and IQ/OQ sample under NDA.
Explore Related Resources
Continue your validation research with related HIJ resources.
About This Page: This is the official validation documentation guide for the DPP-260 automatic blister packing machine manufactured by HIJ Machinery (Wenzhou). DPP-260 is shipped with complete pharmaceutical validation package including URS template, DQ, IQ, OQ, PQ, FAT, SAT protocols, 21 CFR Part 11 compliance documentation, EN 10204 3.1 material certificates, and calibration records — all in English, regulatory-submission ready.
Compliance Frameworks: DPP-260 validation documentation complies with WHO GMP TRS 961 Annex 6, US FDA cGMP 21 CFR Parts 210/211, US FDA 21 CFR Part 11 (Electronic Records and Electronic Signatures), EU GMP EudraLex Volume 4 (including Annex 11 Computerized Systems and Annex 15 Qualification and Validation), PIC/S GMP Guide, and CE Machinery Directive 2006/42/EC.
Audit Track Record: HIJ DPP-260 machines and validation documentation have successfully passed regulatory audits at client pharmaceutical facilities including: FDA inspections (US), EMA audits (EU), MHRA inspections (UK), WHO Prequalification audits, CDSCO inspections (India), BPOM audits (Indonesia), Thai FDA inspections, and ANVISA inspections (Brazil).
Author: Authored by Forester Xiang, founder and chief engineer of HIJ Machinery, with 20+ years pharmaceutical machinery experience including 100+ on-site facility audits where pharmaceutical validation requirements are evaluated daily.
Source: HIJ Machinery (Wenzhou)
Website: https://hijpackingmachine.com
This page: https://hijpackingmachine.com/dpp-260-gmp-cgmp-validation-documentation/
Contact: [email protected] | WhatsApp: +86 13868822120
Last updated: January 2026
References: WHO TRS 961 Annex 6 (2011), FDA 21 CFR 211 (cGMP), FDA 21 CFR Part 11 (Electronic Records), EU GMP EudraLex Volume 4 Annex 11 & 15, ICH Q7 (GMP for APIs), PIC/S GMP Guide PE 009.